SK5642000A3 - CRYSTALLINE POLYMORPHIC FORM OF 1,3-DICYCLOPROPYLMETHYL-8-AMINOì (54) XANTHINE, PROCESS FOR ITS PRODUCTION, PHARMACEUTICALì - Google Patents
CRYSTALLINE POLYMORPHIC FORM OF 1,3-DICYCLOPROPYLMETHYL-8-AMINOì (54) XANTHINE, PROCESS FOR ITS PRODUCTION, PHARMACEUTICALì Download PDFInfo
- Publication number
- SK5642000A3 SK5642000A3 SK564-2000A SK5642000A SK5642000A3 SK 5642000 A3 SK5642000 A3 SK 5642000A3 SK 5642000 A SK5642000 A SK 5642000A SK 5642000 A3 SK5642000 A3 SK 5642000A3
- Authority
- SK
- Slovakia
- Prior art keywords
- dicyclopropylmethyl
- polymorphic form
- xanthine
- amino
- crystalline polymorphic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6323897P | 1997-10-23 | 1997-10-23 | |
| PCT/US1998/022451 WO1999020625A1 (fr) | 1997-10-23 | 1998-10-23 | Nouvelles formes polymorphes de cipamfylline |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK5642000A3 true SK5642000A3 (en) | 2000-09-12 |
Family
ID=22047900
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK564-2000A SK5642000A3 (en) | 1997-10-23 | 1998-10-23 | CRYSTALLINE POLYMORPHIC FORM OF 1,3-DICYCLOPROPYLMETHYL-8-AMINOì (54) XANTHINE, PROCESS FOR ITS PRODUCTION, PHARMACEUTICALì |
Country Status (28)
| Country | Link |
|---|---|
| US (2) | US6583283B1 (fr) |
| EP (1) | EP1025103A4 (fr) |
| JP (1) | JP2001520228A (fr) |
| KR (1) | KR20010031246A (fr) |
| CN (1) | CN1280579A (fr) |
| AP (1) | AP2000001793A0 (fr) |
| AR (1) | AR015190A1 (fr) |
| AU (1) | AU751561B2 (fr) |
| BG (1) | BG104368A (fr) |
| BR (1) | BR9814099A (fr) |
| CA (1) | CA2306980A1 (fr) |
| CO (1) | CO4990930A1 (fr) |
| DZ (1) | DZ2629A1 (fr) |
| EA (1) | EA003445B1 (fr) |
| HU (1) | HUP0100019A3 (fr) |
| ID (1) | ID23885A (fr) |
| IL (1) | IL135711A0 (fr) |
| MA (1) | MA24682A1 (fr) |
| NO (1) | NO20002012L (fr) |
| NZ (1) | NZ504051A (fr) |
| PE (1) | PE122599A1 (fr) |
| PL (1) | PL340257A1 (fr) |
| SA (1) | SA99191117A (fr) |
| SK (1) | SK5642000A3 (fr) |
| TR (1) | TR200001109T2 (fr) |
| UY (2) | UY25220A1 (fr) |
| WO (1) | WO1999020625A1 (fr) |
| ZA (1) | ZA989622B (fr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004520386A (ja) | 2001-01-31 | 2004-07-08 | ファイザー・プロダクツ・インク | Ｐｄｅ４アイソザイムの阻害剤として有用なニコチンアミドビアリール誘導体 |
| PL364910A1 (en) | 2001-01-31 | 2004-12-27 | Pfizer Products Inc. | Ether derivatives useful as inhibitors of pde4 isozymes |
| HUP0401305A2 (hu) | 2001-01-31 | 2004-10-28 | Pfizer Products Inc. | Tiazolil-, oxazolil-, pirrolil- és imidazolil-savamid-származékok, mint PDE4 izozimek inhibitorai és az ezeket tartalmazó gyógyszerkészítmények |
| US7250518B2 (en) | 2001-01-31 | 2007-07-31 | Pfizer Inc. | Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes |
| DE60319980T2 (de) * | 2002-05-31 | 2009-04-16 | Schering Corporation | Xanthin-phosphodiesterase-v-hemmer polymorphe |
| JP2008503446A (ja) | 2004-05-06 | 2008-02-07 | プレキシコン，インコーポレーテッド | Ｐｄｅ４ｂ阻害剤及びその使用 |
| JP2008512380A (ja) | 2004-09-03 | 2008-04-24 | プレキシコン，インコーポレーテッド | Ｐｄｅ４ｂ阻害剤 |
| US7435818B2 (en) * | 2005-09-20 | 2008-10-14 | Scinopharm Taiwan, Ltd. | Crystal forms of irinotecan hydrochloride |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8906792D0 (en) | 1989-03-23 | 1989-05-10 | Beecham Wuelfing Gmbh & Co Kg | Treatment and compounds |
| GB9020921D0 (en) | 1990-09-26 | 1990-11-07 | Beecham Group Plc | Novel compounds |
| GB9020959D0 (en) | 1990-09-26 | 1990-11-07 | Beecham Group Plc | Novel compounds |
-
1998
- 1998-10-21 MA MA25309A patent/MA24682A1/fr unknown
- 1998-10-21 AR ARP980105252A patent/AR015190A1/es not_active Application Discontinuation
- 1998-10-21 DZ DZ980239A patent/DZ2629A1/fr active
- 1998-10-22 ZA ZA989622A patent/ZA989622B/xx unknown
- 1998-10-23 US US09/529,865 patent/US6583283B1/en not_active Expired - Fee Related
- 1998-10-23 SK SK564-2000A patent/SK5642000A3/sk unknown
- 1998-10-23 AU AU12744/99A patent/AU751561B2/en not_active Ceased
- 1998-10-23 CN CN98810380A patent/CN1280579A/zh active Pending
- 1998-10-23 EA EA200000448A patent/EA003445B1/ru not_active IP Right Cessation
- 1998-10-23 ID IDW20000714A patent/ID23885A/id unknown
- 1998-10-23 TR TR2000/01109T patent/TR200001109T2/xx unknown
- 1998-10-23 WO PCT/US1998/022451 patent/WO1999020625A1/fr not_active Application Discontinuation
- 1998-10-23 CO CO98061838A patent/CO4990930A1/es unknown
- 1998-10-23 KR KR1020007004228A patent/KR20010031246A/ko not_active Application Discontinuation
- 1998-10-23 HU HU0100019A patent/HUP0100019A3/hu unknown
- 1998-10-23 PE PE1998001002A patent/PE122599A1/es not_active Application Discontinuation
- 1998-10-23 PL PL98340257A patent/PL340257A1/xx unknown
- 1998-10-23 NZ NZ504051A patent/NZ504051A/xx unknown
- 1998-10-23 EP EP98956156A patent/EP1025103A4/fr not_active Withdrawn
- 1998-10-23 BR BR9814099-0A patent/BR9814099A/pt not_active IP Right Cessation
- 1998-10-23 CA CA002306980A patent/CA2306980A1/fr not_active Abandoned
- 1998-10-23 UY UY25220A patent/UY25220A1/es not_active Application Discontinuation
- 1998-10-23 IL IL13571198A patent/IL135711A0/xx unknown
- 1998-10-23 JP JP2000516967A patent/JP2001520228A/ja not_active Withdrawn
- 1998-10-23 AP APAP/P/2000/001793A patent/AP2000001793A0/en unknown
-
1999
- 1999-02-04 UY UY25380A patent/UY25380A1/es not_active IP Right Cessation
- 1999-02-27 SA SA99191117A patent/SA99191117A/ar unknown
-
2000
- 2000-04-17 NO NO20002012A patent/NO20002012L/no not_active Application Discontinuation
- 2000-04-21 BG BG104368A patent/BG104368A/xx unknown
-
2002
- 2002-04-18 US US10/125,754 patent/US20020173648A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| UY25380A1 (es) | 1999-11-17 |
| CO4990930A1 (es) | 2000-12-26 |
| IL135711A0 (en) | 2001-05-20 |
| SA99191117A (ar) | 2005-12-03 |
| PE122599A1 (es) | 2000-02-12 |
| TR200001109T2 (tr) | 2000-09-21 |
| MA24682A1 (fr) | 1999-07-01 |
| UY25220A1 (es) | 2001-08-27 |
| CN1280579A (zh) | 2001-01-17 |
| EP1025103A1 (fr) | 2000-08-09 |
| AU1274499A (en) | 1999-05-10 |
| ID23885A (id) | 2000-05-25 |
| CA2306980A1 (fr) | 1999-04-29 |
| NO20002012D0 (no) | 2000-04-17 |
| EA003445B1 (ru) | 2003-06-26 |
| AP2000001793A0 (en) | 2000-06-30 |
| WO1999020625A1 (fr) | 1999-04-29 |
| HUP0100019A3 (en) | 2003-01-28 |
| AR015190A1 (es) | 2001-04-18 |
| JP2001520228A (ja) | 2001-10-30 |
| US20020173648A1 (en) | 2002-11-21 |
| PL340257A1 (en) | 2001-01-29 |
| KR20010031246A (ko) | 2001-04-16 |
| NO20002012L (no) | 2000-04-17 |
| AU751561B2 (en) | 2002-08-22 |
| EP1025103A4 (fr) | 2001-11-14 |
| BG104368A (en) | 2001-02-28 |
| ZA989622B (en) | 1999-04-23 |
| BR9814099A (pt) | 2000-10-10 |
| DZ2629A1 (fr) | 2003-03-08 |
| NZ504051A (en) | 2003-02-28 |
| HUP0100019A2 (hu) | 2002-01-28 |
| US6583283B1 (en) | 2003-06-24 |
| EA200000448A1 (ru) | 2000-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI729530B (zh) | 吡咯并〔２，３－ｄ〕嘧啶甲苯磺酸鹽類、其晶形以及其製造方法及中間體 | |
| US8022228B2 (en) | Crystal form of asenapine maleate | |
| EP1908756A1 (fr) | Procédés pour la préparation de sodium de mycophénolate cristallin | |
| KR20100122948A (ko) | 치환된 헤테로사이클 융합 감마-카볼라인 고체 | |
| EP1917267A1 (fr) | Forme cristalline du maléate d'asenapine | |
| CN107531678A (zh) | Egfr抑制剂及其药学上可接受的盐和多晶型物及其应用 | |
| GB2558514A (en) | Process for the synthesis of stable amorphous ibrutinib | |
| SK5642000A3 (en) | CRYSTALLINE POLYMORPHIC FORM OF 1,3-DICYCLOPROPYLMETHYL-8-AMINOì (54) XANTHINE, PROCESS FOR ITS PRODUCTION, PHARMACEUTICALì | |
| CN110950847B (zh) | 氘代azd9291化合物的新晶型及其用途 | |
| CN116829549A (zh) | 6-(环丙烷甲酰胺基)-4-((2-甲氧基-3-(1-甲基-1H-1,2,4-三唑-3-基)苯基)氨基)-N-(甲基-d３)哒嗪-3-甲酰胺的晶型 | |
| CA3130247C (fr) | Compose inhibiteur de fgfr sous forme solide et son procede de preparation | |
| EP2069337A1 (fr) | Sels de maléate, de tosylate, de fumarate et d'oxalate du 5-(1(s)-amino-2-hydroxyéthyl)-n-ý(2,4-difluorophényl)-méthyl¨-2-ý8-méthoxy-2-(trifluorométhyl)-5-quinoline¨-4-oxazolecarboxamide et leur procédé d'obtention | |
| KR20180033514A (ko) | Fgfr 억제제를 제조하기 위한 방법 | |
| US9127018B2 (en) | Solid forms of ortataxel | |
| EP2085397A1 (fr) | Forme cristalline d'abacavir | |
| WO2017032349A1 (fr) | Sels de 5-fluoro-3-phényl-2-[(1s)-1-(9h-purin-6-ylamino)propyl]quinazolin-4-one et préparation de ces derniers | |
| Sperandeo et al. | The crystal structure and physicochemical characteristics of 2-hydroxy-N-[3 (5)-pyrazolyl]-1, 4-naphthoquinone-4-imine, a new antitrypanosomal compound | |
| TWI777535B (zh) | 用於苯并茚前列腺素之中間物的晶體及其製備方法 | |
| CN112830919B (zh) | 苯并哌啶衍生物可药用盐及其制备方法 | |
| WO2012003413A1 (fr) | Nouvelles formes solides de tacédinaline | |
| CZ20001404A3 (cs) | Nové polymorfní formy cipamfylinu | |
| EP1768969B1 (fr) | Mycophenolate de sodium cristallin | |
| CN114249695A (zh) | 一种奥拉帕利的新晶型、制备方法及用途 | |
| MXPA00003857A (en) | Novel polymorphic forms of cipamfylline | |
| CN111718340A (zh) | 氘代Palbociclib化合物的晶型、制备方法及应用 |